Skip to main content
    C

    Cardinal Health Inc (CAH)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $279.24
    -4.61 (-1.62%)

    Market Cap: $65.61B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Cardinal Health Inc (CAH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cardinal Health (CAH) has a market cap of $65.61B and an enterprise value of $69.16B. Its trailing P/E of 23.3x is above its 10-year median of 13.2x. Its return on invested capital of 37.56% compares with a 9.62% median across 12 similar companies.

    Total Valuation

    Enterprise value is 5.41% above the market cap, as debt exceeds cash.

    Market Cap$65.61B
    Enterprise Value$69.16B
    Latest price (Nov 17, 2026)$279.24

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Jan 4, 2027.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Next Ex-Dividend DateJan 4, 2027
    Next Payment DateJan 15, 2027
    Fiscal Year EndJune

    Share Statistics

    The share count shrank 2.33% a year over 3 years.

    Shares Outstanding232.00M
    Shares Change (YoY)-2.52%
    Share Count Growth (3Y CAGR)-2.33%

    Valuation Ratios

    The price to sales ratio is 0.3x. Its year-end P/E ranged from 9.0x to 21.4x from 2016 to 2025.

    P/E Ratio23.3x
    Forward P/E21.8x
    P/S Ratio0.3x
    Forward P/S0.2x
    P/FCF Ratio13.2x
    P/OCF Ratio11.7x
    PEG Ratio1.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 18.5x EBITDA and 13.9x free cash flow.

    EV / Earnings38.3x
    EV / Sales0.3x
    EV / EBITDA18.5x
    EV / EBIT25.4x
    EV / FCF13.9x

    Price Statistics

    The stock is up 36.64% over 52 weeks and trades 13.73% above its 50-day average.

    Beta (1Y)-0.01
    52-Week Change+36.64%
    1-Month Change+10.52%
    3-Month Change+19.17%
    6-Month Change+39.98%
    5-Year Change+423.91%
    10-Year Change+264.65%
    Total Return (1Y)+37.64%
    Total Return (3Y CAGR)+40.81%
    Total Return (5Y CAGR)+44.11%
    Return vs SPY (1Y)+24.02%
    Max Drawdown (1Y)-20.57%
    Max Drawdown (3Y)-20.57%
    Sharpe Ratio (1Y)1.19
    Correlation with SPY (1Y)-0.01
    50-Day Average$245.53
    200-Day Average$225.17
    52-Week Range$179.64 to $286.29
    RSI (14 Days)71.8
    Average Volume (20 Days)1.69M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.88x current liabilities.

    Current Ratio0.88x
    Quick Ratio0.49x
    Debt / EBITDA2.39x
    Debt / FCF1.80x
    Interest Coverage7.99x

    Returns and Efficiency

    Return on invested capital is 37.56% over the last 12 months, against a 5-year average of 25.23%.

    Return on Assets (ROA)3.03%
    Return on Invested Capital (ROIC)37.56%
    Return on Capital Employed (ROCE)20.62%
    ROA (5Y Average)1.29%
    ROIC (5Y Average)25.23%
    Asset Turnover4.49x
    Inventory Turnover13.88x
    Receivables Turnover18.18x
    Cash Conversion Cycle-12 days

    Taxes

    Income tax took 20.19% of pretax income over the last 12 months.

    Income Tax (TTM)$457.00M
    Effective Tax Rate20.19%

    Scores

    CAH has an Altman Z-Score of 5.05, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score5.05
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $257.75B over the last 12 months is up 10.00% from the 12 months before.

    Revenue$257.75B
    Revenue Growth (YoY)+10.00%
    Gross Profit$10.05B
    Operating Income$2.70B
    Pretax Income$2.26B
    Net Income$1.81B
    EBITDA$3.69B
    EBIT$2.73B
    Reported EPS (TTM)$11.97

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$5.26B
    Total Debt$8.81B
    Net Debt$3.55B
    Net Debt Per Share$15.31
    Working Capital-$5.34B
    Shareholder Equity-$3.02B
    Tangible Book Value-$16.71B
    Total Assets$59.54B
    Total Liabilities$62.41B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $698.00M of capital spending, operating cash flow left $4.90B of free cash flow.

    Operating Cash Flow$5.60B
    Capital Expenditures$698.00M
    Free Cash Flow$4.90B
    FCF Per Share$21.17
    Depreciation and Amortization$970.00M
    Dividends Paid$499.00M
    Share Repurchases$1.48B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 1.05%, against a 5-year average of 0.53%.

    Gross Margin3.90%
    Operating Margin1.05%
    Pretax Margin0.88%
    Net Margin0.70%
    EBITDA Margin1.43%
    EBIT Margin1.06%
    FCF Margin1.90%
    Gross Margin (5Y Average)3.54%
    Operating Margin (5Y Average)0.53%
    Net Margin (5Y Average)0.28%

    Growth

    Revenue grew 7.44% a year over 3 years, and EPS 24.68% a year.

    Revenue Growth (3Y CAGR)+7.44%
    Revenue Growth (5Y CAGR)+9.37%
    EPS Growth (3Y CAGR)+24.68%
    EPS Growth (5Y CAGR)+15.20%
    FCF Growth (3Y CAGR)+24.18%
    FCF Growth (5Y CAGR)+17.40%
    Operating Income Growth (3Y CAGR)+51.46%

    Revenue and profit by year

    Dividends and Yields

    CAH pays out 8.51% of earnings as dividends.

    Dividend Per Share (Annual)$2.06
    Dividend Yield0.74%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+0.91%
    Dividend Growth (5Y CAGR)+0.95%
    Payout Ratio8.51%
    FCF Payout Ratio10.18%
    Earnings Yield4.29%
    FCF Yield7.57%
    Buyback Yield2.29%
    Shareholder Yield3.06%

    Full dividend history

    Stock Splits

    The last split was a 3-for-2 forward split on Apr 23, 2001.

    Last Split DateApr 23, 2001
    Split TypeForward split
    Split Ratio3:2

    Peer Position

    Against 10 similar companies, CAH has the 3rd highest P/E.

    P/E Ratio23.3x vs 15.9x median
    P/S Ratio0.3x vs 0.5x median
    ROIC37.56% vs 9.62% median
    Revenue Growth (Trailing 4 Quarters, YoY)+10.00% vs +7.43% median
    Dividend Yield0.74% vs 0.48% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.39% and EPS growth at 13.01% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.39%
    EPS Growth Forecast (2Y CAGR)+13.01%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CAH

    What is CAH's market cap?

    Cardinal Health has a market cap of $65.61B. Its enterprise value, which adds debt and subtracts cash, is $69.16B.

    What is CAH's P/E ratio?

    Cardinal Health has a trailing P/E ratio of 23.3x and a forward P/E of 21.8x.

    How many shares of CAH are outstanding?

    Cardinal Health has 232.00M shares outstanding. The count is down 2.52% from a year earlier.

    Does CAH pay a dividend?

    Yes. Cardinal Health pays $2.06 a share a year, a dividend yield of 0.74%.

    How much debt does CAH have?

    Cardinal Health has $8.81B of total debt and $5.26B of cash and equivalents, a net debt position of $3.55B.